Your DNA, Your Dose
By April 27, 2026, biomarker-driven stratification allows clinics to predict which specific metabolic pathway is your weakest link, ensuring treatments work the first time.
The Multi-Omics Dashboard
Clinicians use metabolomics to monitor real-time drug response. LSI keywords like 'metabolic phenotyping' are now standard.
Precision Selection Logic
Stratification Index
Strategic Advice: Look for clinics offering 'Metabolic Phenotyping' to save months of ineffective therapy.